Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines. Issue 38 (11th September 2015)

• Record Type: Journal Article
• Authors: DiazGranados, Carlos A.; Robertson, Corwin A.; Talbot, H. Keipp; Landolfi, Victoria; Dunning, Andrew J.; Greenberg, David P.
• Is Part Of: Vaccine. Volume 33:Issue 38(2015)
• Page Start: 4988
• Page End: 4993
• Publication Date: 2015-09-11
• Subjects: Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2015.07.006
• Languages: English
• ISSNs: 0264-410X

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">Randomized trial of high-dose vs. standard-dose influenza vaccines in older adults.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">High-dose vaccine decreased the risk of serious cardio-respiratory events.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">The relative effectiveness against serious pneumonia was 39.8%.</p> </list-item> </list> </p> </sec> </abstract>